Abstract
Protein Misfolding Cyclic Amplification (PMCA) is a 10 years old in vitro technique based on a cyclic process leading to accelerate prion replication in vitro. The technique has been modified and adapted several times since its inception: new ideas, more sophisticated equipments and new applications have been essential elements for its upgrading. PMCA has proved to be an efficient method mimicking in vitro some of the fundamental steps involved in prion replication in vivo. Thus, it can be used to efficiently replicate a variety of infectious prion strains/species maintaining their strain specificity. It is an eminent technique for TSE diagnosis and is being used for detecting prions in blood in presymptomatic samples. On the other hand, the in vitro prion replication has been decisive to prove the protein only hypothesis, thanks to the generation of infectious prions by using substrates based exclusively on recombinant PrPC without any mammalian or synthetic co-factors. These achievements, in addition to the ability of PMCA for generating de novo prions in vitro as well as its use for evaluating the potential risks of different prion strains to humans and animals, make this technique as one of the most important tools from the last decade in the prion field.
Keywords: In vitro replication, PMCA, prion, scrapie, Transmissible Spongiform Encephalopathy (TSE)
Current Chemical Biology
Title: PMCA. A Decade of In Vitro Prion Replication
Volume: 4 Issue: 3
Author(s): Natalia Fernandez-Borges and Joaquin Castilla
Affiliation:
Keywords: In vitro replication, PMCA, prion, scrapie, Transmissible Spongiform Encephalopathy (TSE)
Abstract: Protein Misfolding Cyclic Amplification (PMCA) is a 10 years old in vitro technique based on a cyclic process leading to accelerate prion replication in vitro. The technique has been modified and adapted several times since its inception: new ideas, more sophisticated equipments and new applications have been essential elements for its upgrading. PMCA has proved to be an efficient method mimicking in vitro some of the fundamental steps involved in prion replication in vivo. Thus, it can be used to efficiently replicate a variety of infectious prion strains/species maintaining their strain specificity. It is an eminent technique for TSE diagnosis and is being used for detecting prions in blood in presymptomatic samples. On the other hand, the in vitro prion replication has been decisive to prove the protein only hypothesis, thanks to the generation of infectious prions by using substrates based exclusively on recombinant PrPC without any mammalian or synthetic co-factors. These achievements, in addition to the ability of PMCA for generating de novo prions in vitro as well as its use for evaluating the potential risks of different prion strains to humans and animals, make this technique as one of the most important tools from the last decade in the prion field.
Export Options
About this article
Cite this article as:
Fernandez-Borges Natalia and Castilla Joaquin, PMCA. A Decade of In Vitro Prion Replication, Current Chemical Biology 2010; 4 (3) . https://dx.doi.org/10.2174/2212796811004030200
DOI https://dx.doi.org/10.2174/2212796811004030200 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytokines in Systemic Lupus Erythematosus
Current Molecular Medicine Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists
Current Pharmaceutical Design Possible Pathomechanisms Responsible for Injury to the Central Nervous System in the Settings of Chronic Cerebrospinal Venous Insufficiency
Reviews on Recent Clinical Trials Methods of Preparation of Multifunctional Microbubbles and their In Vitro / In Vivo Assessment of Stability, Functional and Structural Properties
Current Pharmaceutical Design Basolateral Aggregated Rat Amyloidβ(1-42) Potentiates Transmigration of Primary Rat Monocytes through a Rat Blood-Brain Barrier
Current Neurovascular Research Human Cancer Cell Line Based Approach of 1,3,4-thiadiazole and its Fused Ring: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Medicinal Chemistry of Selective Neurokinin-1 Antagonists
Current Topics in Medicinal Chemistry Peri-Procedural Care of Renal Nerve Ablation Candidates
Current Clinical Pharmacology Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases
Current Drug Targets Appraisal of Nano-Lipidic Astaxanthin cum Thermoreversible Gel and its Efficacy in Haloperidol Induced Parkinsonism
Current Drug Delivery Silence of the Genes: A Targeted Approach to the Suppression of Specific Genes in Human Disease Using Small Interfering RNA (siRNA)
Current Genomics Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design Drainage of Cerebral Abscesses Prior to Valve Replacement in Stable Patients with Acute Left-Sided Infective Endocarditis
CNS & Neurological Disorders - Drug Targets Giant Cell Arteritis – A Series of Cases and Review of Literature
Current Rheumatology Reviews Pain Alleviation in Anti-Inflammatory and Anti-Allergic Conditions
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Iron Supplementation Therapy in End-Stage Renal Disease Patients on Maintenance Hemodialysis
Cardiovascular & Hematological Disorders-Drug Targets Botulinum Toxin: Pharmacology and Clinical Developments: A Literature Review
Medicinal Chemistry The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy
Current Pharmaceutical Design Glucose Metabolism and Insulin Resistance in Sepsis
Current Pharmaceutical Design Elective Caesarean Delivery - the Right Choice for whom?
Current Women`s Health Reviews